For healthcare professionals only

News Extra [these Stories Appear Only On The Web]

Drug industry writers propose code of ethical conduct

BMJ 2002; 324 doi: (Published 06 April 2002) Cite this as: BMJ 2002;324:808
  1. Gavin Yamey
  1. Oakland

    A group of pharmaceutical industry writers is urging all drug companies to adopt a new code of conduct that gives guidance on ethical publication practice.

    The code, called Good Publication Practice for Pharmaceutical Companies, includes a commitment to register and publish all trials and to avoid redundant or duplicate publication.

    The code was discussed at last week's …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription